Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1184 | 1027 | 1248 | 1113 | 1773 | 2791 |
Fund Return | 18.42% | 2.66% | 24.81% | 3.65% | 12.13% | 10.81% |
Place in category | 898 | 1079 | 908 | 732 | 268 | 98 |
% in Category | 34 | 41 | 34 | 33 | 17 | 12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cap Group New Perspective lux C GBP | 15.93B | 18.93 | 4.21 | - | ||
Cap Group NewPerspective lux ZL GBP | 15.93B | 18.31 | 3.62 | 10.80 | ||
Cap Group NewPerspective lux A7 GBP | 15.93B | 18.44 | 3.76 | - | ||
CapGroup NewPerspectiveLux ZLgd GBP | 15.93B | 18.28 | 3.62 | 10.80 | ||
Cap Group Glbl Eq lux A4 GBP | 627.36M | 18.51 | 7.06 | 10.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU2322252383 | 15.93B | 18.24 | 3.54 | - | ||
Cap Group New Perspective lux C GBP | 15.93B | 18.93 | 4.21 | - | ||
Cap Group NewPerspective lux ZL GBP | 15.93B | 18.31 | 3.62 | 10.80 | ||
Cap Group NewPerspective lux A7 GBP | 15.93B | 18.44 | 3.76 | - | ||
CapGroup NewPerspectiveLux ZLgd GBP | 15.93B | 18.28 | 3.62 | 10.80 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 3.78 | 599.81 | -0.59% | |
Microsoft | US5949181045 | 3.26 | 430.53 | -1.73% | |
Taiwan Semicon | TW0002330008 | 3.23 | 1,090.00 | +0.46% | |
Broadcom | US11135F1012 | 2.79 | 241.75 | -1.47% | |
Novo Nordisk B | DK0062498333 | 2.50 | 635.9 | +2.14% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Strong Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review